COMPANY PROFILE · /iambic-therapeutics
I
Iambic Therapeutics
AI-driven drug discovery company with a track record of moving compounds to clinical trials rapidly. Proprietary platform has delivered molecules to clinic in under two years. Founded by medicinal chemistry researchers.
Fresh · 9d ago
Latest valuation
estimated $600M
Annual Recurring Revenue
—
Headcount
40+
Funding total
$120M+
OVERVIEW
Closed $100M funding in November 2025, $20M from Ireland Strategic Investment Fund in February 2026. Partners: Lundbeck (neurological disorders), Jazz Pharmaceuticals, Takeda. Clinical candidates advancing.
Status
active
Tier
master-list
Profitability
—
Pricing
enterprise
FUNDING HISTORY · 0
No funding rounds on file.
PRODUCTS · 0
No products catalogued yet. Press Refresh above to ask the research agent.
TEAM · 0 key people
No people linked.
SOURCES · 0 cited
No citations stored yet. Run the research agent to attach per-claim sources.